BlackRock’s Nightstar Therapeutics NITE Stock Holding History
Bought
Maintained
Sold
Other funds holding NITE
BlackRock's NITE Position: Q4 2017 in Review
BlackRock sold out of Nightstar Therapeutics (NITE) in Q4 2017, closing a stake of 325,000 shares — an estimated $6.24M sold.
BlackRock first reported a position in NITE in Q3 2017 and held it in 1 quarter. The position peaked at $6.24M in Q3 2017. 16 funds tracked by Wall St. Rank hold NITE as of Q4 2017.
- BlackRock reported no remaining Nightstar Therapeutics position as of Q4 2017 after selling out during the quarter.
- BlackRock sold 325,000 Nightstar Therapeutics shares in Q4 2017, an estimated $6.24M.
- BlackRock first reported a position in Nightstar Therapeutics in Q3 2017 and held it in 1 quarter.
- BlackRock's Nightstar Therapeutics position peaked at $6.24M in Q3 2017.
- 16 funds tracked by Wall St. Rank held Nightstar Therapeutics as of Q4 2017.
Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.